Skip to main content
logo
Alexander & Baldwin, Inc. (ALEX)
NYSE: ALEX · Real-Time Price · USD
18.21
+0.04 (0.22%)
Aug 8, 2025, 4:00 PM - Market closed

Aerovate Therapeutics Revenue

Alexander & Baldwin had revenue of $54.29M in the quarter ending June 30, 2025, with 4.32% growth. This brings the company's revenue in the last twelve months to $238.31M, up 8.21% year-over-year. In the year 2024, Alexander & Baldwin had annual revenue of $241.20M with 14.47% growth.

Revenue (ttm)
$238.31M
Revenue Growth
+8.21%
P/S Ratio
5.55
Revenue / Employee
$2,407,152
Employees
99
Market Cap
1.32B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024241.20M30.48M14.47%
Dec 31, 2023210.72M-21.43M-9.23%
Dec 31, 2022232.15M-39.76M-14.62%
Dec 31, 2021271.90M74.80M37.95%
Dec 31, 2020197.10M-243.40M-55.26%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CBRE Group38.10B
American Tower10.26B
Welltower9.28B
Equinix8.93B
Prologis8.91B
Crown Castle6.47B
Simon Property Group6.03B
Digital Realty Trust5.69B
Revenue Rankings

ALEX News

More News